| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.04 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.21 | 0.05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.32 | 0.05 |